Efficacy and Safety of Low-Dose Systemic Fibrinolytic Therapy for Acute Submassive Pulmonary Embolism
- PMID: 33826502
- DOI: 10.1016/j.jcin.2021.01.043
Efficacy and Safety of Low-Dose Systemic Fibrinolytic Therapy for Acute Submassive Pulmonary Embolism
Comment in
-
Reply: Efficacy and Safety of Low-Dose Systemic Fibrinolytic Therapy for Acute Submassive Pulmonary Embolism.JACC Cardiovasc Interv. 2021 Apr 12;14(7):810. doi: 10.1016/j.jcin.2021.02.009. JACC Cardiovasc Interv. 2021. PMID: 33826504 No abstract available.
Comment on
-
Indigo Aspiration System for Treatment of Pulmonary Embolism: Results of the EXTRACT-PE Trial.JACC Cardiovasc Interv. 2021 Feb 8;14(3):319-329. doi: 10.1016/j.jcin.2020.09.053. Epub 2021 Jan 13. JACC Cardiovasc Interv. 2021. PMID: 33454291
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical